Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:38:22.370Z.
Calculation as of: 2026-10-06T16:38:22.370Z.
Quote observation: 2026-10-06T16:35:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c752279377b025acf72c3dd079155b3811244be546b74823e0a9f28be94cffb5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$43.42M
EV/FCF Ratio
12.90x
TTM Avg
37.31x
3Y Avg
6410.23x
5Y Avg
6410.23x
Market Cap
$42.29M
EV/FCF Ratio
N/A
TTM Avg
16.14x
3Y Avg
18.58x
5Y Avg
128.19x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $43.85M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.42M | 12.90x | 37.31x | 6410.23x | 6410.23x |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.31M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.85M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| Precipio, Inc. (PRPO)vs › | $41.92M | 53.46x | 75.69x | 62.69x | 62.69x |
| DarioHealth Corp. (DRIO)vs › | $45.37M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $42.29M | N/A | 16.14x | 18.58x | 128.19x |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.36M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute